manganese(III) oxide (Mn 2 O 3 ), and Prussian blue nanozyme (PBzyme), etc., have multienzyme-like activities, which enable either the efficient production of reactive oxygen species (ROS) to kill tumor cells and bacteria, or the clearance of ROS to reduce oxidative stress and inflammation. [9][10][11][12][13][14] These metal-based nanozymes display multiple antitumor, anti-infective, and anti-inflammatory activities, and offer promise as potential adjuvants, cotreatments, or alternatives to cytotoxic chemotherapeutics, antibiotics, and nonsteroidal anti-inflammatory drugs. [15][16][17] Most nanozymes in preclinical development have single-enzyme-like activity, and are thus limited by insufficient catalytic efficiency, restricted availability of substrate types and concentrations, and activity under single identifiable catalytic conditions. In comparison, those with multienzyme-like activities carry advantages of high catalytic efficiency via amplification or cascade reactions, adaptive responses to dissimilar catalytic conditions, multifunctionality in diverse pathological processes, and capacities to overcome the impediment of insufficient substrates via "self-provision." [18] At present, most reported nanozymes with multienzyme-like activities are metal-based, owing to their unsaturated sites from the inherent structure of metal atoms and the valence changes of the metal centers in case of transition metals. [4] In the last decade, researchers have studied catalytic effects and regulation rules and design schemes of metal-based nanozymes with multienzyme-like activities (MNMs), with goals to remarkably improve their therapeutic efficiency and broaden their range of applications. [15,[19][20][21][22][23][24][25] Previous review articles have discussed the spatial structures and catalytic mechanisms of nanozymes from the perspective of their physical properties, or have summarized the effects of a few types of nanozymes with potential medical applications. [4,6,[26][27][28][29][30][31][32] However, clinical relevance stands as the core motivator of nanozyme research. Therefore, this review concentrates on MNMs. This work focuses on the biological effects of nanozymes based on their intracellular interactions, intending to analyze mechanisms of action and potential therapeutic applications. Herein, we summarize MNMs, their impacts on pathogenesis, underlying mechanisms, potential medical Most nanozymes in development for medical applications only exhibit singleenzyme-like activity, and are thus limited by insufficient catalytic activity and dysfunctionality in complex pathological microenvironments. To overcome the impediments of limited substrate availabilities and concentrations, some metal-based nanozymes may mimic two or more activities of natural enzymes to catalyze cascade reactions or to catalyze multiple substrates simultaneously, thereby amplifying catalysis. Metal-based nanozymes with multienzyme-like activities (MNMs) may adapt to dissimilar catalytic conditions to exert different enzyme-like effects. ...